Zidovudine and interferon-α treatment induces a high response rate and reduces HTLV-1 proviral load and VEGF plasma levels in patients with adult T-cell leukemia from North East Iran

References

• Hinuma Y, Komoda H, Chosa T, Kondo T, Kohakura M, Takenaka T, et al. Antibodies to adult T-cell associated-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study. Int J Cancer 1982; 29: 631–635
   PubMed Web of Science ®Google Scholar
• Gessain A, Barin F, Vernant J C, Gout O, Maurs L, Calender A, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985; 2: 407–410
   PubMed Web of Science ®Google Scholar
• Takatsuki F, Yamaguchi K, Hattori T. Adult T-cell leukemia/lymphoma. Retrovirus Biology and Human Disease, R C Gallo, F Wong-Staal. Marcel Deker, New York 1990; 147–159
   Google Scholar
• Kaplan J, Khabbaz R. The epidemiology of human T-lymphotropic virus type I and II. Med Virol 1993; 3: 137–148
   Web of Science ®Google Scholar
• Gessain A. Epidemiology of HTLV-I and associated diseases. Human T-Cell Lymphotropic Virus Type 1, P Höllsberg, D A Hafler. Willey, Chichester 1996; 33–64
   Google Scholar
• Safai B, Huang J L, Boeri E, Farid R, Raafat J, Schutzer P, et al. Prevalence of HTLV type I infection in Iran: a serological and genetic study. AIDS Res Hum Retroviruses 1996; 12: 1185–1190
   PubMed Web of Science ®Google Scholar
• Abbaszadegan M R, Gholamin M, Tabatabaee A, Farid R, Houshmand M, Abbaszadegan M. Prevalence of human T-lymphotropic virus type 1 among blood donors from Mashhad. Iran J Clin Microbiol 2003; 41: 2593–2595
   PubMed Web of Science ®Google Scholar
• Bazarbachi A, Ghez D, Lepelletier Y, Nasr R, de The H, El-Sabban M E, et al. New therapeutic approaches for adult T-cell leukaemia. Lancet Oncol 2004; 5: 664–672
   PubMed Web of Science ®Google Scholar
• Shimoyama M. Treatment of patients with adult T-cell lymphoma-lymphoma: an overview. Advances in Adult T-Cell Leukaemia and HTLV-I Research, Vol. 39, K Takatsuki, Y Hinuma, M Yoshida. Japan Scientific Societies Press, Tokyo 1992; 43–56
   Google Scholar
• Yamada Y, Tomonaga M, Fukuda H, Hanada S, Utsunomiya A, Tara M, et al. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol 2001; 113: 375–382
   PubMed Web of Science ®Google Scholar
• Hermine O, Bouscary D, Gessain A, Turlure P, LeBlond V, Franck N, et al. Treatment of HTLV-I associated adult T-cell lymphoma-lymphoma with a combination of zidovudine and α-interferon. N Engl J Med 1995; 332: 1749–1751
   PubMed Web of Science ®Google Scholar
• Gill P, Harrington W, Kaplan M, Ribeiro R C, Bennett J M, Liebman H A, et al. Treatment of adult T-cell lymphoma-lymphoma with a combination of interferon-α and zidovudine. N Engl J Med 1995; 332: 1744–1748
   PubMed Web of Science ®Google Scholar
• Bazarbachi A, Hermine O. Treatment by a combination of zidovudine and α-interferon in naive and pretreated Adult T-cell lymphoma/lymphoma patients. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13: S186–S190
   PubMedGoogle Scholar
• Hermine O, Allard I, Lévy V, Arnulf B, Gessain A, Bazarbachi A. For the French ATL therapy group. A prospective phase II clinical trial with the use of zidovudine and interferon-α in the acute and lymphoma forms of adult T-cell lymphoma/lymphoma. Hematol J 2002; 3: 276–282
   PubMedGoogle Scholar
• Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002; 29: 15–18
   PubMed Web of Science ®Google Scholar
• El-Sabban M, Abu Merhi R, Abi Haidar H, Arnulf B, Basbous J, Khoury H, et al. Human T-cell lymphotropic virus type I transformed cells induce angiogenesis and establish functional gap junctions with endothelial cells. Blood 2002; 99: 3383–3389
   PubMed Web of Science ®Google Scholar
• Bazarbachi A, Merhi R A, Gessain A, Talhouk R, El-Khoury H, Nasr R, et al. Human T-cell lymphotropic virus type I-infected cells extravasate through the endothelial barrier by a local angiogenesis-like mechanism. Cancer Res 2004; 64: 2039–2046
   PubMed Web of Science ®Google Scholar
• Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984 – 1987). Br J Haematol 1991; 79: 428–437
   PubMed Web of Science ®Google Scholar
• Okayama A, Stuver S, Matsuoka M, Ishizaki J, Tanaka G, Kubuki Y, et al. Role of HTLV-1 proviral DNA load and clonality in the development of adult T-cell leukemia/lymphoma in asymptomatic carriers. Int J Cancer 2004; 110: 621–625
   PubMed Web of Science ®Google Scholar
• Hayashibara T, Yamada Y, Miyanishi T, Mori H, Joh T, Maeda T, et al. Vascular endothelial growth factor and cellular chemotaxis: a possible autocrine pathway in adult T-cell leukemia cell invasion. Clin Cancer Res 2001; 7: 2719–2726
   PubMed Web of Science ®Google Scholar
• Kamihira S, Dateki N, Sugahara K, Hayashi T, Harasawa H, Minami S, et al. Significance of HTLV-1 proviral load quantification by real-time PCR as a surrogate marker for HTLV-1-infected cell count. Clin Lab Haematol 2003; 25: 111–117
   PubMedGoogle Scholar
• Taylor G P, Hall S E, Navarrete S, Michie C A, Davis R, Witkover A D, et al. Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy. J Virol 1999; 73: 10289–10295
   PubMed Web of Science ®Google Scholar
• Machuca A, Soriano V. In vivo fluctuation of HTLV-I and HTLV-II proviral load in patients receiving antiretroviral drugs. J Acquir Immune Defic Syndr 2000; 24: 189–193
   PubMed Web of Science ®Google Scholar
• Bazarbachi A, Nasr R, El-Sabban M E, Mahe A, Mahieux R, Gessain A, et al. Evidence against a direct cytotoxic effect of α-interferon and zidovudine in HTLV-I associated adult T cell lymphoma/lymphoma. Leukaemia 2000; 14: 716–721
   PubMed Web of Science ®Google Scholar
• Macchi B, Faraoni I, Zhang J, Grelli S, Favalli C, Mastino A, et al. AZT inhibits the transmission of human T cell leukaemia/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro. J Gen Virol 1997; 78: 1007–1016
   PubMed Web of Science ®Google Scholar
• Isono T, Ogawa K, Seto A. Antiviral effect of zidovudine in the experimental model of adult T cell leukaemia in rabbits. Leuk Res 1990; 14: 841–847
   PubMed Web of Science ®Google Scholar
• Oguma S, Imamura Y, Kusumoto Y. Accelerated declining tendency of human T-cell leukaemia virus type I carrier rates among younger blood donnors in Kumamoto, Japan. Cancer Res 1992; 52: 2620–2626
   PubMed Web of Science ®Google Scholar
• Feng X, Heyden N V, Ratner L. α-Interferon inhibits human T-cell leukaemia virus type 1 assembly by preventing Gag interaction with rafts. J Virol 2003; 77: 13389–13395
   PubMed Web of Science ®Google Scholar
• Datta A, Bellon M, Sinha-Datta U, Bazarbachi A, Lepelletier Y, Canioni D, et al. Persistent inhibition of telomerase reprograms adult T-cell leukaemia to p53-dependent senescence. Blood 2006; 108: 1021–1029
   PubMed Web of Science ®Google Scholar